Menu Back toCreating-Value-for-Scientific-Exchange


Creating Value for Patients

Session Chair(s)

Jennifer  Burgess, MBA, MPH

Jennifer Burgess, MBA, MPH

  • Vice President, Global Engagement and Communications
  • TransCelerate BioPharma Inc., United States
Creating Value for Patients
Learning Objective : Learning about the many challenges in the set-up of appropriate processes for the writing, review, approval and distribution of lay summaries, appeciating the complexity of providing translations of lay summaries for all study participants, appreciating the choices that need to be made for lay summaries of early phase trials


Thomas M. Schindler, PhD

Bringing Lay Summaries to Fruition - How to Implement Appropriate Processes

Thomas M. Schindler, PhD

  • Head Medical Writing Europe
  • Boehringer Ingelheim Pharma GmbH & Co.KG, Germany
Hugo  Riu

Best Practices for Lay Summaries in Global Clinical Trials

Hugo Riu

  • Quality and Training Director
  • Welocalize Life Sciences, Spain
Fabian  Somers, PhD, MBA, MSc

Enabling Patient Centric Clinical Trials: TransCelerate’s Patient Experience Initiative

Fabian Somers, PhD, MBA, MSc

  • Senior Clinical Program Director, NewMeds & Bone Clinical Development
  • UCB Biopharma, Belgium
Srinivas  Karri, MSc

Patient Engagement Through Patient Centricity

Srinivas Karri, MSc

  • Senior Director, Clinical Warehousing Cloud Strategy
  • Oracle Corporation, United Kingdom